Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2013, 14(11), 22221-22232; doi:10.3390/ijms141122221
Article

Combination BMSC and Niaspan Treatment of Stroke Enhances White Matter Remodeling and Synaptic Protein Expression in Diabetic Rats

1,†
, 2,3,†
, 2,4
, 2
, 2
, 2,4
, 2
 and 2,*
Received: 1 August 2013; in revised form: 16 October 2013 / Accepted: 18 October 2013 / Published: 11 November 2013
(This article belongs to the Special Issue Pathology and Treatment of Central Nervous System Diseases)
View Full-Text   |   Download PDF [1266 KB, updated 19 June 2014; original version uploaded 19 June 2014]
Abstract: Objective: White matter remodeling plays an important role in neurological recovery after stroke. Bone marrow stromal cells (BMSCs) and Niaspan, an agent which increases high density lipoprotein (HDL), each induces neurorestorative effects and promotes white matter remodeling after stroke in non-diabetic rats. In this study, we test whether combination of BMSCs with Niaspan induces an enhanced white matter remodeling in the ischemic brain of diabetic rats. Research design and methods: Type-1 diabetes (T1DM) rats were subjected to transient middle cerebral artery occlusion (MCAo) and treated with or without BMSCs; Niaspan; and the combination of BMSCs + Niaspan daily for 14 days after MCAo. Immunostaining for white matter remodeling and synaptic protein expression including NG2; CNPase; BS (Bielschowsky silver); LFB (luxol fast blue); Synaptophysin and SMI-31 immunostaining were performed. Results: BMSC monotherapy did not regulate NG2 and CNPase expression compared to T1DM control rats. Both, combination of BMSCs + Niaspan treatment, and Niaspan monotherapy significantly increase NG2 and CNPase expression compared to T1DM control. While combination BMSC+Niaspan, BMSC monotherapy and Niaspan monotherapy groups all increase BS, LFB, synaptophysin, and SMI-31 expression in the ischemic brain compared to T1DM-MCAo control. In addition, the combination treatment significantly enhances LFB, SMI-31, and Synaptophysin expression compared to BMSC monotherapy. Conclusions: Combination treatment of stroke with BMSCs and Niaspan in T1DM rats increases white matter remodeling and additively increases BMSC monotherapy induced myelination and synaptic plasticity after stroke in T1DM rats.
Keywords: type-one diabetic rats; stroke; bone marrow stromal cells; Niaspan; white matter remodeling; synaptic plasticity type-one diabetic rats; stroke; bone marrow stromal cells; Niaspan; white matter remodeling; synaptic plasticity
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Ye, X.; Yan, T.; Chopp, M.; Zacharek, A.; Ning, R.; Venkat, P.; Roberts, C.; Chen, J. Combination BMSC and Niaspan Treatment of Stroke Enhances White Matter Remodeling and Synaptic Protein Expression in Diabetic Rats. Int. J. Mol. Sci. 2013, 14, 22221-22232.

AMA Style

Ye X, Yan T, Chopp M, Zacharek A, Ning R, Venkat P, Roberts C, Chen J. Combination BMSC and Niaspan Treatment of Stroke Enhances White Matter Remodeling and Synaptic Protein Expression in Diabetic Rats. International Journal of Molecular Sciences. 2013; 14(11):22221-22232.

Chicago/Turabian Style

Ye, Xinchun; Yan, Tao; Chopp, Michael; Zacharek, Alex; Ning, Ruizhuo; Venkat, Poornima; Roberts, Cynthia; Chen, Jieli. 2013. "Combination BMSC and Niaspan Treatment of Stroke Enhances White Matter Remodeling and Synaptic Protein Expression in Diabetic Rats." Int. J. Mol. Sci. 14, no. 11: 22221-22232.



Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert